| P2093 | author name string | Hong Li | |
| | Christina M L Kelton | |
| | Jeff J Guo | |
| | Yonghua Jing | |
| | Patricia R Wigle | |
| | Jeffery A Demland | |
| P2860 | cites work | Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 |
| | Effectiveness of antipsychotic drugs in patients with chronic schizophrenia | Q28273164 |
| | Inadequate pharmacotherapeutic data for drugs used in children: what can be done? | Q30606847 |
| | Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs. | Q34213637 |
| | Off-label prescribing among office-based physicians | Q34523020 |
| | Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. | Q35631515 |
| | Psychiatric and medical comorbidities of bipolar disorder | Q36021272 |
| | Screening for bipolar disorder in a primary care practice | Q36053183 |
| | Bipolar disorder: improving diagnosis and optimizing integrated care | Q36658039 |
| | Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population | Q37052217 |
| | Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children | Q37300756 |
| | Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. | Q39675765 |
| | Characteristics and risk factors associated with high-cost Medicaid recipients | Q39699994 |
| | An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population | Q39702815 |
| | Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials | Q42615199 |
| | Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach | Q43817449 |
| | Clozapine and venous thromboembolism | Q43977672 |
| | Screening for bipolar disorder in the community | Q44318544 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism | Q44791353 |
| | Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 |
| | Off-label uses of drugs in children. | Q51443331 |
| | The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates. | Q51949363 |
| | Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study. | Q54767360 |
| | Bipolar–panic comorbidity in the general population: prevalence and associated morbidity | Q59480879 |
| | The emerging epidemiology of hypomania and bipolar II disorder | Q77700788 |
| | Off-label marketing stirs a legal hornet's nest | Q79304549 |
| | Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001 | Q79927165 |
| | The effect of hypertension and obesity on the development of diabetes mellitus in patients treated with atypical antipsychotic drugs | Q80277286 |
| | Practice guideline for the treatment of patients with bipolar disorder (revision) | Q95789383 |
| P433 | issue | 4 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 184-191 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | American health & drug benefits | Q26842282 |
| P1476 | title | Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002 | |
| P478 | volume | 2 | |